Luathaich provides executive-level operating leadership within BioPharma organizations — integrating enterprise strategy, capital deployment, and operating execution across Manufacturing & Supply, Quality, and CMC & Technical Operations.
Engagements support enterprise decisions that shape company trajectory — including operating model design, capital allocation, strategic contracting, and execution discipline — while maintaining direct accountability for performance within core technical functions.
The differentiator is operating range. Experience spans from shop floor execution to board-level dialogue. When enterprise decisions are made, their downstream impact across functions and levels is anticipated early — ensuring strategy, capital, and execution remain aligned under real operating conditions.
Luathaich remains engaged through implementation until performance is stable and can be sustained by the organization.
Luathaich works on the decisions that sit with the CEO and executive team — the ones that determine whether enterprise execution accelerates or stalls. We operate within the company’s decision structure, where accountability already lives.
Many organizations can align around what should happen. Luathaich remains engaged as decisions move through implementation — where plans meet resistance, trade-offs surface, and execution credibility is built or lost.
Experience spans from the shop floor to the C-suite. When operating changes are made within Manufacturing & Supply, Quality, or CMC & Technical Operations, their downstream impact across functions and levels is anticipated early — what will strain under scale, where friction will surface, and what must be true for performance to hold.
Engagements may include interim or fractional executive roles, or defined enterprise operating mandates, each structured with a clear objective and transition. The focus is strengthening how decisions are made, how execution is governed, and how accountability is reinforced — so performance can be sustained by the organization after we step away..
Luathaich is brought in during periods of scale, transition, regulatory scrutiny, capital deployment, or strategic growth — when enterprise performance depends on disciplined decisions carried through to durable execution.
Bryan Gillis is an operating executive with more than 25 years of leadership across BioPharma Manufacturing & Supply, Quality, and CMC & Technical Operations. He has served in senior roles spanning the shop floor to the C-suite, with direct accountability for enterprise operating performance where regulatory credibility, capital discipline, and execution risk converge.
Bryan is engaged when operating decisions carry enterprise consequence — whether building foundational operating capability in early-stage companies, stabilizing performance under regulatory pressure, or guiding organizations through scale, financing, and commercial transition. He works directly with CEOs, Boards, and investors to align strategy, capital deployment, and operating execution into systems designed to hold under pressure.
His experience includes regulatory remediation, complex manufacturing expansion, CMC strategy development, and enterprise operating model design across North America, Europe, and Asia. Across each engagement, the focus remains consistent: disciplined decision-making, structural clarity, and execution credibility that strengthens enterprise value over time.
Through Luathaich, Bryan provides executive-level operating leadership that integrates enterprise strategy with durable operating performance.
Organizations don’t fail all at once — they drift until something breaks. Most execution problems are decision problems that show up late.
MBA, LSSBB